Dear Trader...
Fund
Houses Recommendations
- Citi on PayTM: Maintain Buy on
Company, target price at Rs 1215/Sh (Positive)
- Jefferies on Belrise: Maintain Buy
on Company, raise target price at Rs 160/Sh (Positive)
- Jefferies on Zydus Life: Maintain Buy
on Company, target price at Rs 1150/Sh (Positive)
- Nomura on Zydus Life: Maintain Buy
on Company, target price at Rs 1140/Sh (Positive)
- Jefferies on Belrise: Maintain Buy
on Company, target price at Rs 135/Sh (Positive)
- Jefferies on Honasa Consumer: Maintain
Buy on Company, target price at Rs 400/Sh (Positive)
- CLSA on Honasa Consumer: Maintain Buy
on Company, target price at Rs 333/Sh (Positive)
- MS on Nykaa: Maintain Overweight
on Company, target price at Rs 225/Sh (Positive)
- Nuvama on Nykaa: Maintain Buy on
Company, target price at Rs 235/Sh (Positive)
- Nomura on Nykaa: Maintain Buy on
Company, target price at Rs 223/Sh (Positive)
- MS on JSPL: Maintain Equal
weight on Company, target price at Rs 950/Sh
(Positive)
- Citi on Apollo Hospitals: Maintain Buy
on Company, target price at Rs 8260/Sh (Positive)
- Investec on Suzlon: Maintain Buy on
Company, target price at Rs 70/Sh (Positive)
- Jefferies on Dr Agrawal: Maintain
Hold on Company, raise target price at Rs 430/Sh (Positive)
- Nomura on Alkem: Maintain Buy on
Company, raise target price at Rs 5430/Sh (Positive)
- MOSL on HAL: Maintain Buy on
Company, target price at Rs 5800/Sh (Positive)
- Nuvama on HAL: Maintain Buy on
Company, target price at Rs 6000/Sh (Positive)
- Nomura on HAL: Maintain Buy on
Company, target price at Rs 6100/Sh (Positive)
- Nuvama on BDL: Maintain Buy on
Company, target price at Rs 2250/Sh (Positive)
- MOSL on BDL: Upgrade to Buy on
Company, target price at Rs 1900/Sh (Positive)
- Jefferies on ONGC: Maintain Buy on
Company, target price at Rs 360/Sh (Positive)
- CLSA on NHPC: Maintain Buy on
Company, target price at Rs 117/Sh (Positive)
- MS on CPI Inflation: July print in-line;
food prices show mixed trend in August, headline CPI likely to rise to 2.5%
YoY. Expect another rate cut in October as growth outlook appears softer than
RBI’s estimates (Positive)
- Nuvama on CPI Inflation: Disinflation
deepens, time for RBI to ease and fiscal push to support growth (Positive)
- Jefferies on Aavas Fin: Maintain
Buy on Company, cut target price at Rs 2175/Sh
(Neutral)
- MS on HAL: Maintain Equal
weight on Company, target price at Rs 5092/Sh
(Neutral)
- Macquarie on Hindalco: Maintain
Outperform on Company, target price at Rs 709/Sh
(Neutral)
- Nuvama on Hindalco: Maintain Buy
on Company, cut target price at Rs 757/Sh (Neutral)
- Bernstein on PayTM: Maintain
Outperform on Company, target price at Rs 1100/Sh (Neutral)
- Nuvama on Titagarh Rail: Maintain
Buy on Company, cut target price at Rs 1142/Sh
(Neutral)
- Nuvama on Minda Corp: Maintain Buy
on Company, cut target price at Rs 590/Sh (Neutral)
- Nomura on Apollo Hospitals: Maintain
Neutral on Company, target price at Rs 6856/Sh
(Neutral)
- Jefferies on Hindalco: Maintain
Hold on Company, target price at Rs 690/Sh
(Neutral)
- CLSA on Hindalco: Maintain Outperform
on Company, target price at Rs 850/Sh (Neutral)
- Nuvama on Hindalco: Maintain Buy
on Company, target price at Rs 776/Sh (Neutral)
- MOSL on Hindalco: Maintain Buy on
Company, target price at Rs 790/Sh (Neutral)
Warm Regards...
Join Channel :- https://whatsapp.com/channel/0029VaVkaZX8Pgs7nE7Hk33O
The securities quoted are for illustration only and are not recommendatory. Investment in securities market are subject to market risks. Read and agree Disclaimer and related all the documents carefully before investing, mentioned on www.nikhilbhatt.in
No comments:
Post a Comment